Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004). (Q33366299)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004). |
scientific article |
Statements
1 reference
Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004). (English)
1 reference
Cancer and Leukemia Group B
1 reference
Antonius A Miller
1 reference
James E Herndon
1 reference
Lin Gu
1 reference
Mark R Green
1 reference
23 January 2005
1 reference
1 reference
48
1 reference
399-407
1 reference
Identifiers
1 reference
1 reference